These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 29247540

  • 1. Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults.
    Serris A, Amoura Z, Canouï-Poitrine F, Terrier B, Hachulla E, Costedoat-Chalumeau N, Papo T, Lambotte O, Saadoun D, Hié M, Blanche P, Lioger B, Gottenberg JE, Godeau B, Michel M.
    Am J Hematol; 2018 Mar; 93(3):424-429. PubMed ID: 29247540
    [Abstract] [Full Text] [Related]

  • 2. Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus.
    Olfat M, Silverman ED, Levy DM.
    Lupus; 2015 Aug; 24(9):966-72. PubMed ID: 25804672
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and Safety of Rituximab in Systemic Lupus Erythematosus and Sjögren Syndrome Patients With Refractory Thrombocytopenia: A Retrospective Study of 21 Cases.
    Jiang B, Li T, Guo L, Shen H, Ye S, Chen S.
    J Clin Rheumatol; 2015 Aug; 21(5):244-50. PubMed ID: 26203828
    [Abstract] [Full Text] [Related]

  • 4. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
    Shanafelt TD, Madueme HL, Wolf RC, Tefferi A.
    Mayo Clin Proc; 2003 Nov; 78(11):1340-6. PubMed ID: 14601692
    [Abstract] [Full Text] [Related]

  • 5. Low-dose rituximab therapy in steroid-refractory thrombocytopenia due to systemic lupus erythematosus.
    Ilizaliturri-Guerra O, Uriarte-Botello R, Pineda-Sic RÁ, Serna-Peña G, Garza-Elizondo MA, Galarza-Delgado DÁ, Leal-Bramasco AS, Elizondo-Solís CV, Santoyo-Fexas L, Villarreal-Alarcón MÁ.
    Rheumatol Int; 2020 Oct; 40(10):1717-1724. PubMed ID: 32797277
    [Abstract] [Full Text] [Related]

  • 6. Successful treatment of a patient with refractory immune thrombocytopenic purpura in systemic lupus erythematosus with rituximab.
    Abe K, Ishikawa Y, Ishikawa J, Fujiwara M, Kita Y.
    Immunol Med; 2019 Dec; 42(4):185-188. PubMed ID: 31794352
    [Abstract] [Full Text] [Related]

  • 7. B-cell depletion for autoimmune thrombocytopenia and autoimmune hemolytic anemia in pediatric systemic lupus erythematosus.
    Kumar S, Benseler SM, Kirby-Allen M, Silverman ED.
    Pediatrics; 2009 Jan; 123(1):e159-63. PubMed ID: 19074962
    [Abstract] [Full Text] [Related]

  • 8. Anti B-cell therapy against refractory thrombocytopenia in SLE and MCTD patients: long-term follow-up and review of the literature.
    Jovancevic B, Lindholm C, Pullerits R.
    Lupus; 2013 Jun; 22(7):664-74. PubMed ID: 23612795
    [Abstract] [Full Text] [Related]

  • 9. Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia.
    Rossignol J, Michallet AS, Oberic L, Picard M, Garon A, Willekens C, Dulery R, Leleu X, Cazin B, Ysebaert L.
    Leukemia; 2011 Mar; 25(3):473-8. PubMed ID: 21127498
    [Abstract] [Full Text] [Related]

  • 10. Autoimmune haemolytic anaemia and autoimmune thrombocytopenia in childhood-onset systemic lupus erythematosus: updates on pathogenesis and treatment.
    Neely J, von Scheven E.
    Curr Opin Rheumatol; 2018 Sep; 30(5):498-505. PubMed ID: 29979258
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of Whole-Blood Exchange Transfusion in Refractory Severe Autoimmune Haemolytic Anaemia Secondary to Systemic Lupus Erythematosus: A Real-World Observational Retrospective Study.
    Jiang Y, Zhao HJ, Luo H, Li BJ, Zhang ZM, Zhao LD, Zuo XX.
    Front Immunol; 2022 Sep; 13():861719. PubMed ID: 35757744
    [Abstract] [Full Text] [Related]

  • 12. Clinical Features of Systemic Lupus Erythematosus Patients Complicated With Evans Syndrome: A Case-Control, Single Center Study.
    Zhang L, Wu X, Wang L, Li J, Chen H, Zhao Y, Zheng W.
    Medicine (Baltimore); 2016 Apr; 95(15):e3279. PubMed ID: 27082565
    [Abstract] [Full Text] [Related]

  • 13. Sirolimus is effective for primary relapsed/refractory autoimmune cytopenia: a multicenter study.
    Li H, Ji J, Du Y, Huang Y, Gu H, Chen M, Wu R, Han B.
    Exp Hematol; 2020 Sep; 89():87-95. PubMed ID: 32771553
    [Abstract] [Full Text] [Related]

  • 14. The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases.
    Michel M, Chanet V, Dechartres A, Morin AS, Piette JC, Cirasino L, Emilia G, Zaja F, Ruggeri M, Andrès E, Bierling P, Godeau B, Rodeghiero F.
    Blood; 2009 Oct 08; 114(15):3167-72. PubMed ID: 19638626
    [Abstract] [Full Text] [Related]

  • 15. The effect of treatment with Campath-1H in patients with autoimmune cytopenias.
    Willis F, Marsh JC, Bevan DH, Killick SB, Lucas G, Griffiths R, Ouwehand W, Hale G, Waldmann H, Gordon-Smith EC.
    Br J Haematol; 2001 Sep 08; 114(4):891-8. PubMed ID: 11564082
    [Abstract] [Full Text] [Related]

  • 16. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
    Dierickx D, Verhoef G, Van Hoof A, Mineur P, Roest A, Triffet A, Kentos A, Pierre P, Boulet D, Bries G, Lê PQ, Janssens A, Delannoy A.
    J Intern Med; 2009 Nov 08; 266(5):484-91. PubMed ID: 19549092
    [Abstract] [Full Text] [Related]

  • 17. Relapses are common in severe hematologic systemic lupus erythematosus and may be prevented by early institution of immunosuppressive agents: Α real-life single-center study.
    Moysidou GS, Garantziotis P, Nikolopoulos D, Katsimbri P, Fanouriakis A, Boumpas DT.
    Lupus; 2023 Feb 08; 32(2):225-230. PubMed ID: 36490217
    [Abstract] [Full Text] [Related]

  • 18. Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 35 cases.
    Ramos-Casals M, García-Carrasco M, López-Medrano F, Trejo O, Forns X, López-Guillermo A, Muñoz C, Ingelmo M, Font J.
    Medicine (Baltimore); 2003 Mar 08; 82(2):87-96. PubMed ID: 12640185
    [Abstract] [Full Text] [Related]

  • 19. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
    Zaja F, Iacona I, Masolini P, Russo D, Sperotto A, Prosdocimo S, Patriarca F, de Vita S, Regazzi M, Baccarani M, Fanin R.
    Haematologica; 2002 Feb 08; 87(2):189-95. PubMed ID: 11836170
    [Abstract] [Full Text] [Related]

  • 20. Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry.
    Terrier B, Amoura Z, Ravaud P, Hachulla E, Jouenne R, Combe B, Bonnet C, Cacoub P, Cantagrel A, de Bandt M, Fain O, Fautrel B, Gaudin P, Godeau B, Harlé JR, Hot A, Kahn JE, Lambotte O, Larroche C, Léone J, Meyer O, Pallot-Prades B, Pertuiset E, Quartier P, Schaerverbeke T, Sibilia J, Somogyi A, Soubrier M, Vignon E, Bader-Meunier B, Mariette X, Gottenberg JE, Club Rhumatismes et Inflammation.
    Arthritis Rheum; 2010 Aug 08; 62(8):2458-66. PubMed ID: 20506527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.